OA3 HOW DO PRESCRIBERS ACT WHEN A PRODUCT IS WITHDRAWN FROM THE MARKET? FIRST LESSONS FROM THE COX-2 INHIBITORS PATIENTS POST ROFECOXIB STUDY (CIPRES)
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63197-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)63197-X/fulltext
Section Title :
Section Order :
46
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63197-X&doi=10.1016/S1098-3015(10)63197-X